DCprime is shaping the field of relapse vaccines, a new class of oncology vaccines. Staying in touch with us means staying up-to-date on the progress of this novel therapeutic strategy.

Connect with us on the social channels

Press Releases

DCprime and Radboudumc to collaborate

Leiden, The Netherlands and Nijmegen, The Netherlands, March 2019– DCprime and Radboudumc announce that they will collaborate as part of a public-private consortium supported by The Dutch Top Sector Life Sciences and Health, represented by Stichting Life Sciences Health – TKI, also acting under its trade name Health~Holland, under the

Read More »

Jeroen Rovers MD, PhD joins DCprime as Chief Medical Officer

Leiden, The Netherlands, October 01, 2018 – DCprime announces today that Jeroen Rovers MD, PhD joins the company as its Chief Medical Officer with immediate effect. Jeroen trained as a pharmaceutical physician at the European Center of Pharmaceutical Medicine in Basel. In the past 15 years he worked in different

Read More »